Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1985 Dec;48(12):1193–1207. doi: 10.1136/jnnp.48.12.1193

Treatment of peripheral neuropathies.

M Hallett, D Tandon, A Berardelli
PMCID: PMC1028602  PMID: 3003254

Abstract

There are three general approaches to treatment of peripheral neuropathy. First, an attempt should be made to reverse the pathophysiological process if its nature can be elucidated. Second, nerve metabolism can be stimulated and regeneration encouraged. Third, even if the neuropathy itself cannot be improved, symptomatic therapy can be employed. This review outlines the options available for each approach.

Full text

PDF
1193

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUSTIN J. H. Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain. 1958 Jun;81(2):157–192. doi: 10.1093/brain/81.2.157. [DOI] [PubMed] [Google Scholar]
  2. Abella R., Blondeel N. J., Roguska J., Walker C., Simon N. M., Del Greco F. Periodic dialysis in terminal uremia. JAMA. 1967 Feb 6;199(6):362–368. [PubMed] [Google Scholar]
  3. Abella R., Blondeel N. J., Roguska J., Walker C., Simon N. M., Del Greco F. Periodic dialysis in terminal uremia. JAMA. 1967 Feb 6;199(6):362–368. [PubMed] [Google Scholar]
  4. Abrams G. M., Latov N., Hays A. P., Sherman W., Zimmerman E. A. Immunocytochemical studies of human peripheral nerve with serum from patients with polyneuropathy and paraproteinemia. Neurology. 1982 Aug;32(8):821–826. doi: 10.1212/wnl.32.8.821. [DOI] [PubMed] [Google Scholar]
  5. Albert M. L. Letter: Carbamazepine for painful post-traumatic paresthesia. N Engl J Med. 1974 Mar 21;290(12):693–693. doi: 10.1056/NEJM197403212901222. [DOI] [PubMed] [Google Scholar]
  6. Aporti F., Finesso M. Effetto dei gangliosidi nelle polinevriti tossiche sperimentali. Med Lav. 1977 Jul-Aug;68(4):296–302. [PubMed] [Google Scholar]
  7. Archer A. G., Watkins P. J., Thomas P. K., Sharma A. K., Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry. 1983 Jun;46(6):491–499. doi: 10.1136/jnnp.46.6.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Arvin A. M., Kushner J. H., Feldman S., Baehner R. L., Hammond D., Merigan T. C. Human leukocyte interferon for the treatment of varicella in children with cancer. N Engl J Med. 1982 Apr 1;306(13):761–765. doi: 10.1056/NEJM198204013061301. [DOI] [PubMed] [Google Scholar]
  9. Ashton H., Beveridge G. W., Stevenson C. J. Management of herpes zoster. Br J Dermatol. 1969 Nov;81(11):874–876. doi: 10.1111/j.1365-2133.1969.tb15965.x. [DOI] [PubMed] [Google Scholar]
  10. Augustin P., Rathery M. Essai clinique de l'isaxonine dans les neuropathies diabétiques. Nouv Presse Med. 1982 Apr 8;11(16):1265–1268. [PubMed] [Google Scholar]
  11. Azizi E., Zaidman J. L., Eshchar J., Szeinberg A. Abetalipoproteinemia treated with parenteral and oral vitamins A and E, and with medium chain triglycerides. Acta Paediatr Scand. 1978 Nov;67(6):796–801. doi: 10.1111/j.1651-2227.1978.tb16264.x. [DOI] [PubMed] [Google Scholar]
  12. BIEHL J. P., VILTER R. W. Effect of isoniazid on vitamin B6 metabolism; its possible significance in producing isoniazid neuritis. Proc Soc Exp Biol Med. 1954 Mar;85(3):389–392. doi: 10.3181/00379727-85-20891. [DOI] [PubMed] [Google Scholar]
  13. BLOM S. TIC DOULOUREUX TREATED WITH NEW ANTICONVULSANT; EXPERIENCES WITH G 32883. Arch Neurol. 1963 Sep;9:285–290. doi: 10.1001/archneur.1963.00460090091009. [DOI] [PubMed] [Google Scholar]
  14. BRADLEY J. J. SEVERE LOCALIZED PAIN ASSOCIATED WITH THE DEPRESSIVE SYNDROME. Br J Psychiatry. 1963 Nov;109:741–745. doi: 10.1192/bjp.109.463.741. [DOI] [PubMed] [Google Scholar]
  15. Babb A. L., Popovich R. P., Christopher T. G., Scribner B. H. The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs. 1971;17:81–91. [PubMed] [Google Scholar]
  16. Balfour H. H., Jr, Bean B., Laskin O. L., Ambinder R. F., Meyers J. D., Wade J. C., Zaia J. A., Aeppli D., Kirk L. E., Segreti A. C. Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med. 1983 Jun 16;308(24):1448–1453. doi: 10.1056/NEJM198306163082404. [DOI] [PubMed] [Google Scholar]
  17. Bassi S., Albizzati M. G., Calloni E., Frattola L. Electromyographic study of diabetic and alcoholic polyneuropathic patients treated with gangliosides. Muscle Nerve. 1982 May-Jun;5(5):351–356. doi: 10.1002/mus.880050503. [DOI] [PubMed] [Google Scholar]
  18. Bates J. A., Nathan P. W. Transcutaneous electrical nerve stimulation for chronic pain. Anaesthesia. 1980 Aug;35(8):817–822. doi: 10.1111/j.1365-2044.1980.tb03926.x. [DOI] [PubMed] [Google Scholar]
  19. Battla H., Silverblatt C. W. Clinical trial of amitriptyline and fluphenazine in diabetic peripheral neuropathy. South Med J. 1981 Apr;74(4):417–418. doi: 10.1097/00007611-198104000-00011. [DOI] [PubMed] [Google Scholar]
  20. Bean B., Braun C., Balfour H. H., Jr Acyclovir therapy for acute herpes zoster. Lancet. 1982 Jul 17;2(8290):118–121. doi: 10.1016/s0140-6736(82)91090-x. [DOI] [PubMed] [Google Scholar]
  21. Berger A., Schaumburg H. H. More on neuropathy from pyridoxine abuse. N Engl J Med. 1984 Oct 11;311(15):986–987. [PubMed] [Google Scholar]
  22. Betourné C., Buge A., Dechy H., Dorra M., Dournon E., Rancurel G. Neuropathies périphériques au cours d'un myélome à IgA et d'une cryoglobulinémie mixte. Traitement par plasmaphérèses itératives. Nouv Presse Med. 1980 Apr 26;9(19):1369–1371. [PubMed] [Google Scholar]
  23. Bohm E. Transcutaneous electrical nerve stimulation in chronic pain after peripheral nerve injury. Acta Neurochir (Wien) 1978;40(3-4):277–283. doi: 10.1007/BF01774752. [DOI] [PubMed] [Google Scholar]
  24. Bolton C. F. Electrophysiologic changes in uremic neuropathy after successful renal transplantation. Neurology. 1976 Feb;26(2):152–161. doi: 10.1212/wnl.26.2.152. [DOI] [PubMed] [Google Scholar]
  25. Bosch E. P., Pierach C. A., Bossenmaier I., Cardinal R., Thorson M. Effect of hematin in porphyric neuropathy. Neurology. 1977 Nov;27(11):1053–1056. doi: 10.1212/wnl.27.11.1053. [DOI] [PubMed] [Google Scholar]
  26. Botney M., Fields H. L. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol. 1983 Feb;13(2):160–164. doi: 10.1002/ana.410130209. [DOI] [PubMed] [Google Scholar]
  27. Boulton A. J., Drury J., Clarke B., Ward J. D. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care. 1982 Jul-Aug;5(4):386–390. doi: 10.2337/diacare.5.4.386. [DOI] [PubMed] [Google Scholar]
  28. Boulton A. J., Worth R. C., Drury J., Hardisty C. A., Wolf E., Cudworth A. G., Ward J. D. Genetic and metabolic studies in diabetic neuropathy. Diabetologia. 1984 Jan;26(1):15–19. doi: 10.1007/BF00252256. [DOI] [PubMed] [Google Scholar]
  29. Bower B. D., Newsholme E. A. Treatment of idiopathic polyneuritis by a polyunsaturated fatty-acid diet. Lancet. 1978 Mar 18;1(8064):583–585. doi: 10.1016/s0140-6736(78)91029-2. [DOI] [PubMed] [Google Scholar]
  30. Bowsher D., Mumford J., Lipton S., Miles J. Treatment of intractable pain by acupuncture. Lancet. 1973 Jul 14;2(7820):57–60. doi: 10.1016/s0140-6736(73)93257-1. [DOI] [PubMed] [Google Scholar]
  31. Brady R. O., Tallman J. F., Johnson W. G., Gal A. E., Leahy W. R., Quirk J. M., Dekaban A. S. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease. N Engl J Med. 1973 Jul 5;289(1):9–14. doi: 10.1056/NEJM197307052890103. [DOI] [PubMed] [Google Scholar]
  32. Brettle R. P., Gross M., Legg N. J., Lockwood M., Pallis C. Treatment of acute polyneuropathy by plasma exchange. Lancet. 1978 Nov 18;2(8099):1100–1100. doi: 10.1016/s0140-6736(78)91837-8. [DOI] [PubMed] [Google Scholar]
  33. Brown M. J., Asbury A. K. Diabetic neuropathy. Ann Neurol. 1984 Jan;15(1):2–12. doi: 10.1002/ana.410150103. [DOI] [PubMed] [Google Scholar]
  34. Brown M. J., Iwamori M., Kishimoto Y., Rapoport B., Moser H. W., Asbury A. K. Nerve lipid abnormalities in human diabetic neuropathy: a correlative study. Ann Neurol. 1979 Mar;5(3):245–252. doi: 10.1002/ana.410050306. [DOI] [PubMed] [Google Scholar]
  35. Buoncristiani U., Mazzotta G., Carobi C., Gallai V., Cozzari M., Di Paolo N. N. Control of uremic neuropathy by equilibrium peritoneal dialysis. Int J Artif Organs. 1984 Mar;7(2):97–100. [PubMed] [Google Scholar]
  36. Caccia M. R., Meola G., Cerri C., Frattola L., Scarlato G., Aporti F. Treatment of denervated muscle by gangliosides. Muscle Nerve. 1979 Sep-Oct;2(5):382–389. doi: 10.1002/mus.880020510. [DOI] [PubMed] [Google Scholar]
  37. Cambier J., Dordain G. Essai contrôlé de l'isaxonine dans les neuropathies de cuase traumatique ou ischémique (par compression). Nouv Presse Med. 1982 Apr 8;11(16):1272–1274. [PubMed] [Google Scholar]
  38. Campbell I. W., Fraser D. M., Ewing D. J., Baldwa V. S., Harrower A. B., Murray A., Neilson J. M., Clarke B. F. Peripheral and autonomic nerve function in diabetic ketoacidosis. Lancet. 1976 Jul 24;2(7978):167–169. doi: 10.1016/s0140-6736(76)92344-8. [DOI] [PubMed] [Google Scholar]
  39. Campbell J. N., Long D. M. Peripheral nerve stimulation in the treatment of intractable pain. J Neurosurg. 1976 Dec;45(6):692–699. doi: 10.3171/jns.1976.45.6.0692. [DOI] [PubMed] [Google Scholar]
  40. Carasso R. L., Yehuda S., Streifler M. Clomipramine and amitriptyline in the treatment of severe pain. Int J Neurosci. 1979;9(3):191–194. doi: 10.3109/00207457909147672. [DOI] [PubMed] [Google Scholar]
  41. Castaigne P., Laplane D., Morales R. Traitement par la clomipramine des douleurs des neuropathies périphériques. 30 observations. Nouv Presse Med. 1979 Mar 10;8(11):843–845. [PubMed] [Google Scholar]
  42. Catizone L., Merlini L., Fusaroli M. La neuropatia periferica dell'uremico in emodialisi periodica: risposta clinica ed elettrofisiologica al trattamento con gangliosidi di corteccia cerebrale. Clin Ter. 1978 May 31;85(4):395–408. [PubMed] [Google Scholar]
  43. Chad D., Pariser K., Bradley W. G., Adelman L. S., Pinn V. W. The pathogenesis of cryoglobulinemic neuropathy. Neurology. 1982 Jul;32(7):725–729. doi: 10.1212/wnl.32.7.725. [DOI] [PubMed] [Google Scholar]
  44. Chadda V. S., Mathur M. S. Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. J Assoc Physicians India. 1978 May;26(5):403–406. [PubMed] [Google Scholar]
  45. Chakrabarti A. K., Samantaray S. K. Diabetic peripheral neuropathy: nerve conduction studies before, during and after carbamazepine therapy. Aust N Z J Med. 1976 Dec;6(6):565–568. doi: 10.1111/j.1445-5994.1976.tb03996.x. [DOI] [PubMed] [Google Scholar]
  46. Chokroverty S., Reyes M. G., Rubino F. A., Tonaki H. The syndrome of diabetic amyotrophy. Ann Neurol. 1977 Sep;2(3):181–194. doi: 10.1002/ana.410020303. [DOI] [PubMed] [Google Scholar]
  47. Clements R. S., Jr, Vourganti B., Kuba T., Oh S. J., Darnell B. Dietary myo-inositol intake and peripheral nerve function in diabetic neuropathy. Metabolism. 1979 Apr;28(4 Suppl 1):477–483. doi: 10.1016/0026-0495(79)90060-x. [DOI] [PubMed] [Google Scholar]
  48. Cockett S. A., Kiernan J. A. Acceleration of peripheral nervous regeneration in the rat by exogenous triiodothyronine. Exp Neurol. 1973 Jun;39(3):389–394. doi: 10.1016/0014-4886(73)90025-3. [DOI] [PubMed] [Google Scholar]
  49. Crepaldi G., Fedele D., Tiengo A., Battistin L., Negrin P., Pozza G., Canal N., Comi G. C., Lenti G., Pagano G. Ganglioside treatment in diabetic peripheral neuropathy: a multicenter trial. Acta Diabetol Lat. 1983 Jul-Sep;20(3):265–276. doi: 10.1007/BF02581271. [DOI] [PubMed] [Google Scholar]
  50. Croft P. B., Urich H., Wilkinson M. Peripheral neuropathy of sensorimotor type associated with malignant disease. Brain. 1967 Mar;90(1):31–66. doi: 10.1093/brain/90.1.31. [DOI] [PubMed] [Google Scholar]
  51. Culebras A., Alió J., Herrera J. L., López-Fraile M. I. Effect of an aldose reductase inhibitor on diabetic peripheral neuropathy. Preliminary report. Arch Neurol. 1981 Feb;38(2):133–134. doi: 10.1001/archneur.1981.00510020091017. [DOI] [PubMed] [Google Scholar]
  52. Dalakas M. C., Engel W. K. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol. 1981;9 (Suppl):134–145. doi: 10.1002/ana.410090719. [DOI] [PubMed] [Google Scholar]
  53. Dalakas M. C., Engel W. K. Polyneuropathy with monoclonal gammopathy: studies of 11 patients. Ann Neurol. 1981 Jul;10(1):45–52. doi: 10.1002/ana.410100109. [DOI] [PubMed] [Google Scholar]
  54. Dalakas M. C., Flaum M. A., Rick M., Engel W. K., Gralnick H. R. Treatment of polyneuropathy in Waldenström's macroglobulinemia: role of paraproteinemia and immunologic studies. Neurology. 1983 Nov;33(11):1406–1410. doi: 10.1212/wnl.33.11.1406. [DOI] [PubMed] [Google Scholar]
  55. Dalessio D. J. Chronic pain syndromes and disordered cortical inhibition: effects of tricyclic compounds. Dis Nerv Syst. 1967 May;28(5):325–328. [PubMed] [Google Scholar]
  56. Davis J. L., Lewis S. B., Gerich J. E., Kaplan R. A., Schultz T. A., Wallin J. D. Peripheral diabetic neuropathy treated with amitriptyline and fluphenazine. JAMA. 1977 Nov 21;238(21):2291–2292. [PubMed] [Google Scholar]
  57. Davis L. E., Drachman D. B. Myeloma neuropathy. Successful treatment of two patients and review of cases. Arch Neurol. 1972 Dec;27(6):507–511. doi: 10.1001/archneur.1972.00490180043010. [DOI] [PubMed] [Google Scholar]
  58. Dehen H. Etude clinique et électrophysiologique de l'isaxonine dans les paralysies faciales périphériques. Nouv Presse Med. 1982 Apr 8;11(16):1262–1264. [PubMed] [Google Scholar]
  59. Dinapoli R. P., Johnson W. J., Lambert E. H. Experience with a combined hemodialysis-renal transplantation program: neurologic aspects. Mayo Clin Proc. 1966 Dec;41(12):809–820. [PubMed] [Google Scholar]
  60. Duthie A. M. The use of phenothiazines and tricyclic antidepressants in the treatment of intractable pain. S Afr Med J. 1977 Feb 19;51(8):246–247. [PubMed] [Google Scholar]
  61. Dyck P. J., Johnson W. J., Nelson R. A., Lambert E. H., O'Brien P. C. Uremic neuropathy. III. Controlled study of restricted protein and fluid diet and infrequent hemodialysis versus conventional hemodialysis treatment. Mayo Clin Proc. 1975 Nov;50(11):641–649. [PubMed] [Google Scholar]
  62. Dyck P. J., Lais A. C., Ohta M., Bastron J. A., Okazaki H., Groover R. V. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc. 1975 Nov;50(11):621–637. [PubMed] [Google Scholar]
  63. Dyck P. J., Lambert E. H. Polyneuropathy associated with hypothyroidism. J Neuropathol Exp Neurol. 1970 Oct;29(4):631–658. doi: 10.1097/00005072-197010000-00008. [DOI] [PubMed] [Google Scholar]
  64. Dyck P. J., O'Brien P. C., Oviatt K. F., Dinapoli R. P., Daube J. R., Bartleson J. D., Mokri B., Swift T., Low P. A., Windebank A. J. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol. 1982 Feb;11(2):136–141. doi: 10.1002/ana.410110205. [DOI] [PubMed] [Google Scholar]
  65. Dyck P. J., Swanson C. J., Low P. A., Bartleson J. D., Lambert E. H. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc. 1982 Apr;57(4):239–246. [PubMed] [Google Scholar]
  66. Eaglstein W. H., Katz R., Brown J. A. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA. 1970 Mar 9;211(10):1681–1683. [PubMed] [Google Scholar]
  67. Ellenberg M. Treatment of diabetic neuropathy with diphenylhydantoin. N Y State J Med. 1968 Oct 15;68(20):2653–2655. [PubMed] [Google Scholar]
  68. Elliott F., Little A., Milbrandt W. Carbamazepine for phantom-limb phenomena. N Engl J Med. 1976 Sep 16;295(12):678–678. doi: 10.1056/NEJM197609162951219. [DOI] [PubMed] [Google Scholar]
  69. Epstein E. Treatment of zoster and postzoster neuralgia by the intralesional injection of triamcinolone: a computer analysis of 199 cases. Int J Dermatol. 1976 Dec;15:762–769. doi: 10.1111/j.1365-4362.1976.tb00177.x. [DOI] [PubMed] [Google Scholar]
  70. Ewing D. J., Campbell I. W., Clarke B. F. Mortality in diabetic autonomic neuropathy. Lancet. 1976 Mar 20;1(7960):601–603. doi: 10.1016/s0140-6736(76)90413-x. [DOI] [PubMed] [Google Scholar]
  71. Ewing D. J., Clarke B. F. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed) 1982 Oct 2;285(6346):916–918. doi: 10.1136/bmj.285.6346.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. FAGERBERG S. E. Diabetic neuropathy: a clinical and histological study on the significance of vascular affections. Acta Med Scand Suppl. 1959;345:1–97. [PubMed] [Google Scholar]
  73. FENNELLY J., FRANK O., BAKER H., LEEVY C. M. PERIPHERAL NEUROPATHY OF THE ALCOHOLIC: I, AETIOLOGICAL ROLE OF ANEURIN AND OTHER B-COMPLEX VITAMINS. Br Med J. 1964 Nov 21;2(5420):1290–1292. doi: 10.1136/bmj.2.5420.1290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Fagius J., Jameson S. Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study. J Neurol Neurosurg Psychiatry. 1981 Nov;44(11):991–1001. doi: 10.1136/jnnp.44.11.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Fauci A. S., Katz P., Haynes B. F., Wolff S. M. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med. 1979 Aug 2;301(5):235–238. doi: 10.1056/NEJM197908023010503. [DOI] [PubMed] [Google Scholar]
  76. Fauci A. S., Wolff S. M. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore) 1973 Nov;52(6):535–561. doi: 10.1097/00005792-197311000-00002. [DOI] [PubMed] [Google Scholar]
  77. Feibel J. H., Campa J. F. Thyrotoxic neuropathy (Basedow's paraplegia). J Neurol Neurosurg Psychiatry. 1976 May;39(5):491–497. doi: 10.1136/jnnp.39.5.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Forrest J. B. The response to epidural steroid injections in chronic dorsal root pain. Can Anaesth Soc J. 1980 Jan;27(1):40–46. doi: 10.1007/BF03006847. [DOI] [PubMed] [Google Scholar]
  79. Forssman O., Leczinsky C. G., Mulder J. Synthetic lysine vasopressin in herpetic neuralgia. Acta Derm Venereol. 1973;53(5):359–362. [PubMed] [Google Scholar]
  80. Fowler H., Vulpe M., Marks G., Egolf C., Dau P. C. Recovery from chronic progressive polyneuropathy after treatment with plasma exchange and cyclophosphamide. Lancet. 1979 Dec 1;2(8153):1193–1193. doi: 10.1016/s0140-6736(79)92423-1. [DOI] [PubMed] [Google Scholar]
  81. Fraser D. M., Campbell I. W., Ewing D. J., Murray A., Neilson J. M., Clarke B. F. Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus. Diabetes. 1977 Jun;26(6):546–550. doi: 10.2337/diab.26.6.546. [DOI] [PubMed] [Google Scholar]
  82. Frick E., Angstwurm H. Zur Kortikosteroid-Behandlung der idiopathischen Polyneuritis. Munch Med Wochenschr. 1968 May 17;110(20):1265–1270. [PubMed] [Google Scholar]
  83. Frohnert P. P., Sheps S. G. Long-term follow-up study of periarteritis nodosa. Am J Med. 1967 Jul;43(1):8–14. doi: 10.1016/0002-9343(67)90144-1. [DOI] [PubMed] [Google Scholar]
  84. GELFAND M. L. Treatment of herpes zoster with cortisone. J Am Med Assoc. 1954 Mar 13;154(11):911–912. [PubMed] [Google Scholar]
  85. GRAVESON G. S. The use of steroids in the treatment of the Guillain-Barre syndrome. Proc R Soc Med. 1961 Jul;54:575–576. doi: 10.1177/003591576105400710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. GRAVESON G. S. The use of steroids in the treatment of the Guillain-Barre syndrome. Proc R Soc Med. 1961 Jul;54:575–576. doi: 10.1177/003591576105400710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Gade G. N., Hofeldt F. D., Treece G. L. Diabetic neuropathic cachexia. Beneficial response to combination therapy with amitriptyline and fluphenazine. JAMA. 1980 Mar 21;243(11):1160–1161. doi: 10.1001/jama.243.11.1160. [DOI] [PubMed] [Google Scholar]
  88. Gersh M. R., Wolf S. L., Rao V. R. Evaluation of transcutaneous electrical nerve stimulation for pain relief in peripheral neuropathy. Phys Ther. 1980 Jan;60(1):48–52. doi: 10.1093/ptj/60.1.48. [DOI] [PubMed] [Google Scholar]
  89. Gerson G. R., Jones R. B., Luscombe D. K. Studies on the concomitant use of carbamazepine and clomipramine for the relief of post-herpetic neuralgia. Postgrad Med J. 1977;53 (Suppl 4):104–109. [PubMed] [Google Scholar]
  90. Gispen W. H., Schotman P. ACTH and brain RNA: changes in content and labelling of RNA in rat brain stem. Neuroendocrinology. 1976;21(2):97–110. doi: 10.1159/000122516. [DOI] [PubMed] [Google Scholar]
  91. Gorio A., Carmignoto G., Facci L., Finesso M. Motor nerve sprouting induced by ganglioside treatment. Possible implications for gangliosides on neuronal growth. Brain Res. 1980 Sep 15;197(1):236–241. doi: 10.1016/0006-8993(80)90451-5. [DOI] [PubMed] [Google Scholar]
  92. Gracey D. R., McMichan J. C., Divertie M. B., Howard F. M., Jr Respiratory failure in Guillain-Barré syndrome: a 6-year experience. Mayo Clin Proc. 1982 Dec;57(12):742–746. [PubMed] [Google Scholar]
  93. Graf R. J., Halter J. B., Halar E., Porte D., Jr Nerve conduction abnormalities in untreated maturity-onset diabetes: relation to levels of fasting plasma glucose and glycosylated hemoglobin. Ann Intern Med. 1979 Mar;90(3):298–303. doi: 10.7326/0003-4819-90-3-298. [DOI] [PubMed] [Google Scholar]
  94. Graf R. J., Halter J. B., Pfeifer M. A., Halar E., Brozovich F., Porte D., Jr Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects. Ann Intern Med. 1981 Mar;94(3):307–311. doi: 10.7326/0003-4819-94-3-307. [DOI] [PubMed] [Google Scholar]
  95. Greene D. A., De Jesus P. V., Jr, Winegrad A. I. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J Clin Invest. 1975 Jun;55(6):1326–1336. doi: 10.1172/JCI108052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Greenwood R. J., Newsom-Davis J., Hughes R. A., Aslan S., Bowden A. N., Chadwick D. W., Gordon N. S., McLellan D. L., Millac P., Stott R. B. Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet. 1984 Apr 21;1(8382):877–879. doi: 10.1016/s0140-6736(84)91341-2. [DOI] [PubMed] [Google Scholar]
  97. Gregersen G., Børsting H., Theil P., Servo C. Myoinositol and function of peripheral nerves in human diabetics. A controlled clinical trial. Acta Neurol Scand. 1978 Oct;58(4):241–248. doi: 10.1111/j.1600-0404.1978.tb02884.x. [DOI] [PubMed] [Google Scholar]
  98. Gregersen G. Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients. Diabetologia. 1968 Nov;4(5):273–277. doi: 10.1007/BF01309900. [DOI] [PubMed] [Google Scholar]
  99. Gross M. L., Legg N. J., Lockwood M. C., Pallis C. The treatment of inflammatory polyneuropathy by plasma exchange. J Neurol Neurosurg Psychiatry. 1982 Aug;45(8):675–679. doi: 10.1136/jnnp.45.8.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Gross M. L., Thomas P. K. The treatment of chronic relapsing and chronic progressive idiopathic inflammatory polyneuropathy by plasma exchange. J Neurol Sci. 1981 Oct;52(1):69–78. doi: 10.1016/0022-510x(81)90135-0. [DOI] [PubMed] [Google Scholar]
  101. Guiheneuc P., Ginet J., Grolleau J. Y., Rojouan J. Etude des effets de l'isaxonine sur les lésions de dégénérescence axonale rétrograde induites chez l'homme par la vincristine. Nouv Presse Med. 1982 Apr 8;11(16):1257–1261. [PubMed] [Google Scholar]
  102. HUGHES H. B., BIEHL J. P., JONES A. P., SCHMIDT L. H. Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis. Am Rev Tuberc. 1954 Aug;70(2):266–273. doi: 10.1164/art.1954.70.2.266. [DOI] [PubMed] [Google Scholar]
  103. Hansson H. A., Holmgren J., Svennerholm L. Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3782–3786. doi: 10.1073/pnas.74.9.3782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Herbison G. J., Jaweed M. M., Ditunno J. F., Jr Exercise therapies in peripheral neuropathies. Arch Phys Med Rehabil. 1983 May;64(5):201–205. [PubMed] [Google Scholar]
  105. Hernandez-Perez E. Dehydroemetine therapy for herpes zoster. A comparison with corticosteroids. Cutis. 1980 Apr;25(4):424–426. [PubMed] [Google Scholar]
  106. Hilton P., Spathis G. S., Stanton S. L. Transient autonomic and sensory neuropathy in newly diagnosed insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1983 Feb 26;286(6366):686–686. doi: 10.1136/bmj.286.6366.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Holman R. R., Dornan T. L., Mayon-White V., Howard-Williams J., Orde-Peckar C., Jenkins L., Steemson J., Rolfe R., Smith B., Barbour D. Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study. Lancet. 1983 Jan 29;1(8318):204–208. doi: 10.1016/s0140-6736(83)92586-2. [DOI] [PubMed] [Google Scholar]
  108. Horowitz S. H., Ginsberg-Fellner F. Ischemia and sensory nerve conduction in diabetes mellitus. Neurology. 1979 May;29(5):695–704. doi: 10.1212/wnl.29.5.695. [DOI] [PubMed] [Google Scholar]
  109. Hreidarsson A. B. Acute, reversible autonomic nervous system abnormalities in juvenile insulin-dependent diabetes. A pupillographic study. Diabetologia. 1981 Apr;20(4):475–481. doi: 10.1007/BF00253411. [DOI] [PubMed] [Google Scholar]
  110. Hugelin A., Legrain Y., Bondoux-Jahan M. Nerve-growth promoting action of isaxonine in rat. Experientia. 1979 May 15;35(5):626–627. doi: 10.1007/BF01960361. [DOI] [PubMed] [Google Scholar]
  111. Hughes R. A., Newsom-Davis J. M., Perkin G. D., Pierce J. M. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978 Oct 7;2(8093):750–753. doi: 10.1016/s0140-6736(78)92644-2. [DOI] [PubMed] [Google Scholar]
  112. Illingworth D. R., Connor W. E., Miller R. G. Abetalipoproteinemia. Report of two cases and review of therapy. Arch Neurol. 1980 Oct;37(10):659–662. doi: 10.1001/archneur.1980.00500590083015. [DOI] [PubMed] [Google Scholar]
  113. JACKSON R. H., MILLER H., SCHAPIRA K. Polyradiculitis (Landry-Guillain-Barré syndrome); treatment with cortisone and corticotrophin. Br Med J. 1957 Mar 2;1(5017):480–484. doi: 10.1136/bmj.1.5017.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Jakobsen J. Early and preventable changes of peripheral nerve structure and function in insulin-deficient diabetic rats. J Neurol Neurosurg Psychiatry. 1979 Jun;42(6):509–518. doi: 10.1136/jnnp.42.6.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Jaspan J., Maselli R., Herold K., Bartkus C. Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function. Lancet. 1983 Oct 1;2(8353):758–762. doi: 10.1016/s0140-6736(83)92296-1. [DOI] [PubMed] [Google Scholar]
  116. Jefferys J. G., Palmano K. P., Sharma A. K., Thomas P. K. Influence of dietary myoinositol on nerve conduction and inositol phospholipids in normal and diabetic rats. J Neurol Neurosurg Psychiatry. 1978 Apr;41(4):333–339. doi: 10.1136/jnnp.41.4.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Johansson F., von Knorring L. A double-blind controlled study of seratonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients. Pain. 1979 Aug;7(1):69–78. doi: 10.1016/0304-3959(79)90108-8. [DOI] [PubMed] [Google Scholar]
  118. Jolly C. Acupuncture and postherpetic neuralgia. Br Med J. 1980 Sep 27;281(6244):871–871. doi: 10.1136/bmj.281.6244.871-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Jones C. L., Gonzalez V. Pyridoxine deficiency: a new factor in diabetic neuropathy. J Am Podiatry Assoc. 1978 Sep;68(9):646–653. doi: 10.7547/87507315-68-9-646. [DOI] [PubMed] [Google Scholar]
  120. Judzewitsch R. G., Jaspan J. B., Polonsky K. S., Weinberg C. R., Halter J. B., Halar E., Pfeifer M. A., Vukadinovic C., Bernstein L., Schneider M. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. N Engl J Med. 1983 Jan 20;308(3):119–125. doi: 10.1056/NEJM198301203080302. [DOI] [PubMed] [Google Scholar]
  121. Jusić A., Sostarko M., Majić D. Long-term ACTH and corticosteroid therapy in two siblings with polyneuropathy due to acute intermittent porphyria. Eur Neurol. 1976;14(4):294–301. doi: 10.1159/000114751. [DOI] [PubMed] [Google Scholar]
  122. Kelly J. J., Jr, Kyle R. A., Miles J. M., Dyck P. J. Osteosclerotic myeloma and peripheral neuropathy. Neurology. 1983 Feb;33(2):202–210. doi: 10.1212/wnl.33.2.202. [DOI] [PubMed] [Google Scholar]
  123. Kennard C., Newland A. C., Ridley A. Treatment of the Guillain-Barré syndrome by plasma exchange. J Neurol Neurosurg Psychiatry. 1982 Sep;45(9):847–850. doi: 10.1136/jnnp.45.9.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Keogh J. P., Pestronk A., Wertheimer D., Moreland R. An epidemic of urinary retention caused by dimethylaminopropionitrile. JAMA. 1980 Feb 22;243(8):746–749. [PubMed] [Google Scholar]
  125. Khan A., Hill J. M., Piga S., Antonetti A. Transfer factor in Guillain-Barré syndrome. Arch Neurol. 1979 Jun;36(6):387–387. doi: 10.1001/archneur.1979.00500420097019. [DOI] [PubMed] [Google Scholar]
  126. Khan M. A., Wakefield G. S., Pugh D. W. Vitamin-B12 deficiency and diabetic neuropathy. Lancet. 1969 Oct 11;2(7624):768–770. doi: 10.1016/s0140-6736(69)90479-6. [DOI] [PubMed] [Google Scholar]
  127. Khurana R. C. Treatment of painful diabetic neuropathy with trazodone. JAMA. 1983 Sep 16;250(11):1392–1392. doi: 10.1001/jama.1983.03340110016015. [DOI] [PubMed] [Google Scholar]
  128. Kocher R. The use of psychotropic drugs in the treatment of chronic, severe pains. Eur Neurol. 1976;14(6):458–464. doi: 10.1159/000114773. [DOI] [PubMed] [Google Scholar]
  129. Konotey-Ahulu F. I., Baillod R., Comty C. M., Heron J. R., Shaldon S., Thomas P. K. Effect of periodic dialysis on the peripheral neuropathy of end-stage renal failure. Br Med J. 1965 Nov 20;2(5472):1212–1215. doi: 10.1136/bmj.2.5472.1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Kosik K. S., Mullins T. F., Bradley W. G., Tempelis L. D., Cretella A. J. Coma and axonal degeneration in vitamin B12 deficiency. Arch Neurol. 1980 Sep;37(9):590–592. doi: 10.1001/archneur.1980.00500580086019. [DOI] [PubMed] [Google Scholar]
  131. Kreiss K., Wegman D. H., Niles C. A., Siroky M. B., Krane R. J., Feldman R. G. Neurological dysfunction of the bladder in workers exposed to dimethylaminopropionitrile. JAMA. 1980 Feb 22;243(8):741–745. [PubMed] [Google Scholar]
  132. Kvinesdal B., Molin J., Frøland A., Gram L. F. Imipramine treatment of painful diabetic neuropathy. JAMA. 1984 Apr 6;251(13):1727–1730. [PubMed] [Google Scholar]
  133. Kyle R. A., Greipp P. R. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc. 1983 Oct;58(10):665–683. [PubMed] [Google Scholar]
  134. Lamontagne A., Buchthal F. Electrophysiological studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry. 1970 Aug;33(4):442–452. doi: 10.1136/jnnp.33.4.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Latov N., Sherman W. H., Nemni R., Galassi G., Shyong J. S., Penn A. S., Chess L., Olarte M. R., Rowland L. P., Osserman E. F. Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. N Engl J Med. 1980 Sep 11;303(11):618–621. doi: 10.1056/NEJM198009113031105. [DOI] [PubMed] [Google Scholar]
  136. Lee R., Spencer P. S. Antidepressants and pain: a review of the pharmacological data supporting the use of certain tricyclics in chronic pain. J Int Med Res. 1977;5(1 Suppl):146–156. [PubMed] [Google Scholar]
  137. Leib E. S., Restivo C., Paulus H. E. Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med. 1979 Dec;67(6):941–947. doi: 10.1016/0002-9343(79)90634-x. [DOI] [PubMed] [Google Scholar]
  138. Levy R. L., Newkirk R., Ochoa J. Treating chronic relapsing Guillain-Barré syndrome by plasma exchange. Lancet. 1979 Aug 4;2(8136):259–260. doi: 10.1016/s0140-6736(79)90276-9. [DOI] [PubMed] [Google Scholar]
  139. Lewin I. G., O'Brien I. A., Morgan M. H., Corrall R. J. Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy. Diabetologia. 1984 Jun;26(6):445–448. doi: 10.1007/BF00262218. [DOI] [PubMed] [Google Scholar]
  140. Lewith G. T., Field J. Acupuncture and postherpetic neuralgia. Br Med J. 1980 Aug 30;281(6240):622–622. doi: 10.1136/bmj.281.6240.622-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Liebeskind J. C., Paul L. A. Psychological and physiological mechanisms of pain. Annu Rev Psychol. 1977;28:41–60. doi: 10.1146/annurev.ps.28.020177.000353. [DOI] [PubMed] [Google Scholar]
  142. Loeser J. D., Black R. G., Christman A. Relief of pain by transcutaneous stimulation. J Neurosurg. 1975 Mar;42(3):308–314. doi: 10.3171/jns.1975.42.3.0308. [DOI] [PubMed] [Google Scholar]
  143. Loh L., Nathan P. W. Painful peripheral states and sympathetic blocks. J Neurol Neurosurg Psychiatry. 1978 Jul;41(7):664–671. doi: 10.1136/jnnp.41.7.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Long D. M. Electrical stimulation for relief of pain from chronic nerve injury. J Neurosurg. 1973 Dec;39(6):718–722. doi: 10.3171/jns.1973.39.6.0718. [DOI] [PubMed] [Google Scholar]
  145. Lowrie E. G., Laird N. M., Parker T. F., Sargent J. A. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med. 1981 Nov 12;305(20):1176–1181. doi: 10.1056/NEJM198111123052003. [DOI] [PubMed] [Google Scholar]
  146. Maas A. I., Busch H. F., van der Heul C. Plasma infusion and plasma exchange in chronic idiopathic polyneuropathy. N Engl J Med. 1981 Aug 6;305(6):344–344. doi: 10.1056/NEJM198108063050614. [DOI] [PubMed] [Google Scholar]
  147. Mamoli B., Brunner G., Mader R., Schanda H. Effects of cerebral gangliosides in the alcoholic polyneuropathies. Eur Neurol. 1980;19(5):320–326. doi: 10.1159/000115168. [DOI] [PubMed] [Google Scholar]
  148. Mapes C. A., Anderson R. L., Sweeley C. C., Desnick R. J., Krivit W. Enzyme replacement in Fabry's disease, an inborn error of metabolism. Science. 1970 Sep 4;169(3949):987–989. doi: 10.1126/science.169.3949.987. [DOI] [PubMed] [Google Scholar]
  149. Masor N. New usage for an old drug in diabetic neuropathy. Value of amphetamines for symptomatic relief. J Natl Med Assoc. 1971 Sep;63(5):380–383. [PMC free article] [PubMed] [Google Scholar]
  150. Matthews W. B., Howell D. A., Hughes R. D. Relapsing corticosteroid-dependent polyneuritis. J Neurol Neurosurg Psychiatry. 1970 Jun;33(3):330–337. doi: 10.1136/jnnp.33.3.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. McCann V. J., Davis R. E. Serum pyridoxal concentrations in patients with diabetic neuropathy. Aust N Z J Med. 1978 Jun;8(3):259–261. doi: 10.1111/j.1445-5994.1978.tb04520.x. [DOI] [PubMed] [Google Scholar]
  152. McGee J. L., Alexander M. R. Phenothiazine analgesia--fact or fantasy? Am J Hosp Pharm. 1979 May;36(5):633–640. [PubMed] [Google Scholar]
  153. McKendrick M. W., McGill J. I., Bell A. M., Hickmott E., Burke C. Oral acyclovir for herpes zoster. Lancet. 1984 Oct 20;2(8408):925–925. doi: 10.1016/s0140-6736(84)90678-0. [DOI] [PubMed] [Google Scholar]
  154. McQuarrie I. G. Nerve regeneration and thyroid hormone treatment. J Neurol Sci. 1975 Dec;26(4):499–502. doi: 10.1016/0022-510x(75)90050-7. [DOI] [PubMed] [Google Scholar]
  155. Meier C., Roberts K., Steck A., Hess C., Miloni E., Tschopp L. Polyneuropathy in Waldenström's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis. Acta Neuropathol. 1984;64(4):297–307. doi: 10.1007/BF00690395. [DOI] [PubMed] [Google Scholar]
  156. Melchior J. C., Clausen J. Metachromatic leucodystrophy in early childhood. Treatment with a diet deficient in vitamin A. Acta Paediatr Scand. 1968 Jan;57(1):2–8. doi: 10.1111/j.1651-2227.1968.tb07276.x. [DOI] [PubMed] [Google Scholar]
  157. Meyer G. A., Fields H. L. Causalgia treated by selective large fibre stimulation of peripheral nerve. Brain. 1972;95(1):163–168. doi: 10.1093/brain/95.1.163. [DOI] [PubMed] [Google Scholar]
  158. Mingione A., Monteleone M., Paruzzi G., Soragni O., Cristiani G., Moretti C., Mega W., Scanabissi F. Research in the use of cerebral gangliosides in neurolysis of the upper limb. Electromyogr Clin Neurophysiol. 1979 Jun-Aug;19(4):353–359. [PubMed] [Google Scholar]
  159. Moore P. M., Cupps T. R. Neurological complications of vasculitis. Ann Neurol. 1983 Aug;14(2):155–167. doi: 10.1002/ana.410140202. [DOI] [PubMed] [Google Scholar]
  160. Moore P. M., Fauci A. S. Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients. Am J Med. 1981 Oct;71(4):517–524. doi: 10.1016/0002-9343(81)90194-7. [DOI] [PubMed] [Google Scholar]
  161. Morgan I. G., Tettamanti G., Gombos G. Biochemical evidence on the role of gangliosides in nerve-endings. Adv Exp Med Biol. 1976;71:137–150. doi: 10.1007/978-1-4614-4614-9_9. [DOI] [PubMed] [Google Scholar]
  162. Morley G. K., Mooradian A. D., Levine A. S., Morley J. E. Mechanism of pain in diabetic peripheral neuropathy. Effect of glucose on pain perception in humans. Am J Med. 1984 Jul;77(1):79–82. doi: 10.1016/0002-9343(84)90439-x. [DOI] [PubMed] [Google Scholar]
  163. Morley J. B., Schwieger A. C. The relation between chronic polyneuropathy and osteosclerotic myeloma. J Neurol Neurosurg Psychiatry. 1967 Oct;30(5):432–442. doi: 10.1136/jnnp.30.5.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Muller D. P., Lloyd J. K. Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia. Ann N Y Acad Sci. 1982;393:133–144. doi: 10.1111/j.1749-6632.1982.tb31239.x. [DOI] [PubMed] [Google Scholar]
  165. Nathan P. W. Chlorprothixene (taractan) in post-herpetic neuralgia and other severe chronic pains. Pain. 1978 Dec;5(4):367–371. doi: 10.1016/0304-3959(78)90005-2. [DOI] [PubMed] [Google Scholar]
  166. Negrin P., Fardin P. Effect of cerebral cortex gangliosides on the clinical and electromyographic evolution of "a frigore" facial paralysis. Apropos of 24 cases. Minerva Med. 1978 Oct 13;69(48):3277–3282. [PubMed] [Google Scholar]
  167. Nielsen V. K. The peripheral nerve function in chronic renal failure. IX. Recovery after renal transplantation. Electrophysiological aspects (sensory and motor nerve conduction). Acta Med Scand. 1974 Mar;195(3):171–180. [PubMed] [Google Scholar]
  168. Norido F., Canella R., Aporti F. Acceleration of nerve regeneration by gangliosides estimated by the somatosensory evoked potentials (SEP). Experientia. 1981 Mar 15;37(3):301–302. doi: 10.1007/BF01991668. [DOI] [PubMed] [Google Scholar]
  169. Norido F., Canella R., Gorio A. Ganglioside treatment of neuropathy in diabetic mice. Muscle Nerve. 1982 Feb;5(2):107–110. doi: 10.1002/mus.880050205. [DOI] [PubMed] [Google Scholar]
  170. Obata K., Oide M., Handa S. Effects of glycolipids on in vitro development of neuromuscular junction. Nature. 1977 Mar 24;266(5600):369–371. doi: 10.1038/266369a0. [DOI] [PubMed] [Google Scholar]
  171. Oh S. J. Subacute demyelinating polyneuropathy responding to corticosteroid treatment. Arch Neurol. 1978 Aug;35(8):509–516. doi: 10.1001/archneur.1978.00500320029007. [DOI] [PubMed] [Google Scholar]
  172. Orlando P., Cocciante G., Ippolito G., Massari P., Roberti S., Tettamanti G. The fate of tritium labeled GM1 ganglioside injected in mice. Pharmacol Res Commun. 1979 Oct;11(9):759–773. doi: 10.1016/s0031-6989(79)80047-8. [DOI] [PubMed] [Google Scholar]
  173. Osterman P. O., Fagius J., Lundemo G., Pihlstedt P., Pirskanen R., Sidén A., Säfwenberg J. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet. 1984 Dec 8;2(8415):1296–1299. doi: 10.1016/s0140-6736(84)90819-5. [DOI] [PubMed] [Google Scholar]
  174. PALMER K. N. POLYRADICULONEUROPATHY (GUILLAIN-BARR'E SYNDROME) TREATED WITH 6-MERCAPTOPURINE. Lancet. 1965 Apr 3;1(7388):733–734. doi: 10.1016/s0140-6736(65)92091-x. [DOI] [PubMed] [Google Scholar]
  175. Pachter B. R., Eberstein A., Goodgold J. Electrical stimulation effect on denervated skeletal myofibers in rats: a light and electron microscopic study. Arch Phys Med Rehabil. 1982 Sep;63(9):427–430. [PubMed] [Google Scholar]
  176. Passouant P., Cadilhac J. Essai de l'isaxonine dans les polynévrites éthyliques. Nouv Presse Med. 1982 Apr 8;11(16):1269–1271. [PubMed] [Google Scholar]
  177. Pecot-Dechavassine M., Mira J. C. Effects of isaxonine on skeletal muscle reinnervation in the rat: an electrophysiologic evaluation. Muscle Nerve. 1985 Feb;8(2):105–114. doi: 10.1002/mus.880080205. [DOI] [PubMed] [Google Scholar]
  178. Pendras J. P., Erickson R. V. Hemodialysis: a successful therapy for chronic uremia. Ann Intern Med. 1966 Feb;64(2):293–311. doi: 10.7326/0003-4819-64-2-293. [DOI] [PubMed] [Google Scholar]
  179. Pentland B., Adams G. G., Mawdsley C. Chronic idiopathic polyneuropathy treated with azathioprine. J Neurol Neurosurg Psychiatry. 1982 Oct;45(10):866–869. doi: 10.1136/jnnp.45.10.866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Perkins H. M., Hanlon P. R. Epidural injection of local anesthetic and steroids for relief of pain secondary to herpes zoster. Arch Surg. 1978 Mar;113(3):253–254. doi: 10.1001/archsurg.1978.01370150025003. [DOI] [PubMed] [Google Scholar]
  181. Peterslund N. A., Seyer-Hansen K., Ipsen J., Esmann V., Schonheyder H., Juhl H. Acyclovir in herpes zoster. Lancet. 1981 Oct 17;2(8251):827–830. doi: 10.1016/s0140-6736(81)91102-8. [DOI] [PubMed] [Google Scholar]
  182. Pietri A., Ehle A. L., Raskin P. Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes. 1980 Aug;29(8):668–671. doi: 10.2337/diab.29.8.668. [DOI] [PubMed] [Google Scholar]
  183. Pollard J. D., McLeod J. G., Gatenby P., Kronenberg H. Prediction of response to plasma exchange in chronic relapsing polyneuropathy. A clinico-pathological correlation. J Neurol Sci. 1983 Feb;58(2):269–287. doi: 10.1016/0022-510x(83)90222-8. [DOI] [PubMed] [Google Scholar]
  184. Pouget J., Gastaut J. L., Vialettes B., Vague P., Serratrice G. Effets du contrôle strict de la glycémie pra pancréas artificiel sur les vitesses de conduction nerveuse chez le diabétique. Rev Electroencephalogr Neurophysiol Clin. 1982 Aug;12(2):135–139. doi: 10.1016/s0370-4475(82)80037-3. [DOI] [PubMed] [Google Scholar]
  185. Prineas J. W., McLeod J. G. Chronic relapsing polyneuritis. J Neurol Sci. 1976 Apr;27(4):427–458. doi: 10.1016/0022-510x(76)90213-6. [DOI] [PubMed] [Google Scholar]
  186. Raji A. R., Bowden R. E. Effects of high-peak pulsed electromagnetic field on the degeneration and regeneration of the common peroneal nerve in rats. J Bone Joint Surg Br. 1983 Aug;65(4):478–492. doi: 10.1302/0301-620X.65B4.6603461. [DOI] [PubMed] [Google Scholar]
  187. Raman T. K., Blake J. A., Harris T. M. Pulmonary embolism in Landry-Guillain-Barre-Strohl syndrome. Chest. 1971 Dec;60(6):555–557. doi: 10.1378/chest.60.6.555. [DOI] [PubMed] [Google Scholar]
  188. Raskin N. H., Levinson S., Hoffman P. M., Pickett J. B., 3rd, Fields H. L. Postsympathectomy neuralgia. Amelioration with diphenylhydantoin and carbamazepine. Am J Surg. 1974 Jul;128(1):75–78. doi: 10.1016/0002-9610(74)90238-4. [DOI] [PubMed] [Google Scholar]
  189. Ravid M., Robson M., Kedar I. Prolonged colchicine treatment in four patients with amyloidosis. Ann Intern Med. 1977 Nov;87(5):568–570. doi: 10.7326/0003-4819-87-5-568. [DOI] [PubMed] [Google Scholar]
  190. Read D., Warlow C. Peripheral neuropathy and solitary plasmacytoma. J Neurol Neurosurg Psychiatry. 1978 Feb;41(2):177–184. doi: 10.1136/jnnp.41.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Rechthand E., Cornblath D. R., Stern B. J., Meyerhoff J. O. Chronic demyelinating polyneuropathy in systemic lupus erythematosus. Neurology. 1984 Oct;34(10):1375–1377. doi: 10.1212/wnl.34.10.1375. [DOI] [PubMed] [Google Scholar]
  192. Reeves M. L., Seigler D. E., Ayyar D. R., Skyler J. S. Medial plantar sensory response. Sensitive indicator of peripheral nerve dysfunction in patients with diabetes mellitus. Am J Med. 1984 May;76(5):842–846. doi: 10.1016/0002-9343(84)90995-1. [DOI] [PubMed] [Google Scholar]
  193. Refsum S. Heredopathia atactica polyneuritiformis phytanic-acid storage disease, Refsum's disease:" a biochemically well-defined disease with a specific dietary treatment. Arch Neurol. 1981 Oct;38(10):605–606. doi: 10.1001/archneur.1981.00510100033003. [DOI] [PubMed] [Google Scholar]
  194. Robertis E., De Lapetina E. G., Fiszer S. Subcellular distribution and possible role of gangliosides in the CNS. Adv Exp Med Biol. 1976;71:105–121. doi: 10.1007/978-1-4614-4614-9_7. [DOI] [PubMed] [Google Scholar]
  195. Robertis E., De Lapetina E. G., Fiszer S. Subcellular distribution and possible role of gangliosides in the CNS. Adv Exp Med Biol. 1976;71:105–121. doi: 10.1007/978-1-4614-4614-9_7. [DOI] [PubMed] [Google Scholar]
  196. Roisen F. J., Bartfeld H., Nagele R., Yorke G. Ganglioside stimulation of axonal sprouting in vitro. Science. 1981 Oct 30;214(4520):577–578. doi: 10.1126/science.7291999. [DOI] [PubMed] [Google Scholar]
  197. Rosen A. D., Vastola E. F. Clinical effects of cyclophosphamide in Guillain-Barré polyneuritis. J Neurol Sci. 1976 Nov;30(1):179–187. doi: 10.1016/0022-510x(76)90265-3. [DOI] [PubMed] [Google Scholar]
  198. Rosenberg N. L., Lacy J. R., Kennaugh R. C., Holers V. M., Neville H. E., Kotzin B. L. Treatment of refractory chronic demyelinating polyneuropathy with lymphoid irradiation. Muscle Nerve. 1985 Mar-Apr;8(3):223–232. doi: 10.1002/mus.880080308. [DOI] [PubMed] [Google Scholar]
  199. Rostand S. G. Vitamin B12 levels and nerve conduction velocities in patients undergoing maintenance hemodialysis. Am J Clin Nutr. 1976 Jul;29(7):691–697. doi: 10.1093/ajcn/29.7.691. [DOI] [PubMed] [Google Scholar]
  200. Rumpl E., Mayr U., Gerstenbrand F., Hackl J. M., Rosmanith P., Aichner F. Treatment of Guillain-Barré syndrome by plasma exchange. J Neurol. 1981;225(3):207–217. doi: 10.1007/BF00313750. [DOI] [PubMed] [Google Scholar]
  201. SCHUPAK E., MERRILL J. P. EXPERIENCE WITH LONG-TERM INTERMITTENT HEMODIALYSIS. Ann Intern Med. 1965 Mar;62:509–518. doi: 10.7326/0003-4819-62-3-509. [DOI] [PubMed] [Google Scholar]
  202. Salar G. L'électrothérapie transcutanée dans le traitement des algies chroniques post-zoostériennes. Ann Anesthesiol Fr. 1978;19(5):417–421. [PubMed] [Google Scholar]
  203. Salway J. G., Whitehead L., Finnegan J. A., Karunanayaka A., Barnett D., Payne R. B. Effect of myo-inositol on peripheral-nerve function in diabetes. Lancet. 1978 Dec 16;2(8103):1282–1284. doi: 10.1016/s0140-6736(78)92043-3. [DOI] [PubMed] [Google Scholar]
  204. Saudek C. D., Werns S., Reidenberg M. M. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther. 1977 Aug;22(2):196–199. doi: 10.1002/cpt1977222196. [DOI] [PubMed] [Google Scholar]
  205. Schatz I. J. Current management concepts in orthostatic hypotension. Arch Intern Med. 1980 Sep;140(9):1152–1154. [PubMed] [Google Scholar]
  206. Schaumburg H., Kaplan J., Windebank A., Vick N., Rasmus S., Pleasure D., Brown M. J. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med. 1983 Aug 25;309(8):445–448. doi: 10.1056/NEJM198308253090801. [DOI] [PubMed] [Google Scholar]
  207. Schreuder M. Pain relief in herpes zoster. S Afr Med J. 1983 May 21;63(21):820–821. [PubMed] [Google Scholar]
  208. Sebille A., Hugelin A. Muscle reinnervation enhanced by isaxonine in man. Br J Clin Pharmacol. 1980 Mar;9(3):275–276. doi: 10.1111/j.1365-2125.1980.tb04838.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Sebille A. Nerve regeneration in exogenous cerebral ganglioside-treated rats. Muscle Nerve. 1984 May;7(4):278–280. doi: 10.1002/mus.880070404. [DOI] [PubMed] [Google Scholar]
  210. Server A. C., Lefkowith J., Braine H., McKhann G. M. Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange. Ann Neurol. 1979 Sep;6(3):258–261. doi: 10.1002/ana.410060313. [DOI] [PubMed] [Google Scholar]
  211. Service F. J., Daube J. R., O'Brien P. C., Dyck P. J. Effect of artificial pancreas treatment on peripheral nerve function in diabetes. Neurology. 1981 Nov;31(11):1375–1380. doi: 10.1212/wnl.31.11.1375. [DOI] [PubMed] [Google Scholar]
  212. Service F. J., Daube J. R., O'Brien P. C., Zimmerman B. R., Swanson C. J., Brennan M. D., Dyck P. J. Effect of blood glucose control on peripheral nerve function in diabetic patients. Mayo Clin Proc. 1983 May;58(5):283–289. [PubMed] [Google Scholar]
  213. Shepard C. C. Leprosy today. N Engl J Med. 1982 Dec 23;307(26):1640–1641. doi: 10.1056/NEJM198212233072608. [DOI] [PubMed] [Google Scholar]
  214. Sherman W. H., Olarte M. R., McKiernan G., Sweeney K., Latov N., Hays A. P. Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia. J Neurol Neurosurg Psychiatry. 1984 Aug;47(8):813–819. doi: 10.1136/jnnp.47.8.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Sivaram C. A., Kapur S., Rao N. S., Chopra J. S. Infective polyneuritis treated with azathioprine (a case report). Neurol India. 1975 Jun;23(2):111–114. [PubMed] [Google Scholar]
  216. Sklar S. H., Blue W. T., Alexander E. J., Bodian C. A. Herpes zoster. The treatment and prevention of neuralgia with adenosine monophosphate. JAMA. 1985 Mar 8;253(10):1427–1430. doi: 10.1001/jama.253.10.1427. [DOI] [PubMed] [Google Scholar]
  217. Snape W. J., Jr, Battle W. M., Schwartz S. S., Braunstein S. N., Goldstein H. A., Alavi A. Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial. Ann Intern Med. 1982 Apr;96(4):444–446. doi: 10.7326/0003-4819-96-4-444. [DOI] [PubMed] [Google Scholar]
  218. Sodipo J. O. Therapeutic acupuncture for chronic pain. Pain. 1979 Dec;7(3):359–365. doi: 10.1016/0304-3959(79)90092-7. [DOI] [PubMed] [Google Scholar]
  219. Strand F. L., Kung T. T. ACTH accelerates recovery of neuromuscular function following crushing of peripheral nerve. Peptides. 1980 Summer;1(2):135–138. doi: 10.1016/0196-9781(80)90077-7. [DOI] [PubMed] [Google Scholar]
  220. Suzuki H., Ogawa S., Nakagawa H., Kanayama T., Tai K., Saitoh H., Ohshima Y. Cryocautery of sensitized skin areas for the relief of pain due to post-herpetic neuralgia. Pain. 1980 Dec;9(3):355–362. doi: 10.1016/0304-3959(80)90049-4. [DOI] [PubMed] [Google Scholar]
  221. Sweet W. H., Wepsic J. G. Stimulation of the posterior columns of the spinal cord for pain control: indications, technique, and results. Clin Neurosurg. 1974;21:278–310. doi: 10.1093/neurosurgery/21.cn_suppl_1.278. [DOI] [PubMed] [Google Scholar]
  222. TENCKHOFF H. A., BOEN S. T., JEBSEN R. H., SPIEGLER J. H. POLYNEUROPATHY IN CHRONIC RENAL INSUFFICIENCY. JAMA. 1965 Jun 28;192:1121–1124. doi: 10.1001/jama.1965.03080260009003. [DOI] [PubMed] [Google Scholar]
  223. Takatsuki K., Sanada I. Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109 reported cases. Jpn J Clin Oncol. 1983 Sep;13(3):543–555. [PubMed] [Google Scholar]
  224. Taub A. Relief of postherpetic neuralgia with psychotropic drugs. J Neurosurg. 1973 Aug;39(2):235–239. doi: 10.3171/jns.1973.39.2.0235. [DOI] [PubMed] [Google Scholar]
  225. Taylor N., Halar E. M., Tenckhoff H., Marchioro T. L., Masock A. J. Effects of renal transplantation on motor nerve conduction velocity. Arch Phys Med Rehabil. 1972 May;53(5):227–231. [PubMed] [Google Scholar]
  226. Terkildsen A. B., Christensen N. J. Reversible nervous abnormalities in juvenile diabetics with recently diagnosed diabetes. Diabetologia. 1971 Apr;7(2):113–117. doi: 10.1007/BF00443891. [DOI] [PubMed] [Google Scholar]
  227. Thoenen H., Barde Y. A. Physiology of nerve growth factor. Physiol Rev. 1980 Oct;60(4):1284–1335. doi: 10.1152/physrev.1980.60.4.1284. [DOI] [PubMed] [Google Scholar]
  228. Thorsteinsson G., Stonnington H. H., Stillwell G. K., Elveback L. R. Transcutaneous electrical stimulation: a double-blind trial of its efficacy for pain. Arch Phys Med Rehabil. 1977 Jan;58(1):8–13. [PubMed] [Google Scholar]
  229. Tong H. I. Influence of neurotropic vitamins on the nerve conduction velocity in diabetic neuropathy. Ann Acad Med Singapore. 1980 Jan;9(1):65–70. [PubMed] [Google Scholar]
  230. Toyka K. V., Augspach R., Paulus W., Grabensee B., Hein D. Plasma exchange in polyradiculoneuropathy. Ann Neurol. 1980 Aug;8(2):205–206. doi: 10.1002/ana.410080223. [DOI] [PubMed] [Google Scholar]
  231. Troni W., Carta Q., Cantello R., Caselle M. T., Rainero I. Peripheral nerve function and metabolic control in diabetes mellitus. Ann Neurol. 1984 Aug;16(2):178–183. doi: 10.1002/ana.410160204. [DOI] [PubMed] [Google Scholar]
  232. Tuck R. R., Schmelzer J. D., Low P. A. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain. 1984 Sep;107(Pt 3):935–950. doi: 10.1093/brain/107.3.935. [DOI] [PubMed] [Google Scholar]
  233. Turkington R. W. Depression masquerading as diabetic neuropathy. JAMA. 1980 Mar 21;243(11):1147–1150. [PubMed] [Google Scholar]
  234. Tyber M. A. Treatment of the painful shoulder syndrome with amitriptyline and lithium carbonate. Can Med Assoc J. 1974 Jul 20;111(2):137–140. [PMC free article] [PubMed] [Google Scholar]
  235. VICTOR M., ADAMS R. D. On the etiology of the alcoholic neurologic diseases with special reference to the role of nutrition. Am J Clin Nutr. 1961 Jul-Aug;9:379–397. doi: 10.1093/ajcn/9.4.379. [DOI] [PubMed] [Google Scholar]
  236. Verghese J. P., Bradley W. G., Mitsumoto H., Chad D. A blind controlled trial of adrenocorticotropin and cerebral gangliosides in nerve regeneration in the rat. Exp Neurol. 1982 Aug;77(2):455–458. doi: 10.1016/0014-4886(82)90256-4. [DOI] [PubMed] [Google Scholar]
  237. WIEDERHOLT W. C., MULDER D. W., LAMBERT E. H. THE LANDRY-GUILLAIN-BARR'E-STROHL SYNDROME OR POLYRADICULONEUROPATHY: HISTORICAL REVIEW, REPORT ON 97 PATIENTS, AND PRESENT CONCEPTS. Mayo Clin Proc. 1964 Jun;39:427–451. [PubMed] [Google Scholar]
  238. Walker G. L. Progressive polyradiculoneuropathy: treatment with Azathioprine. Aust N Z J Med. 1979 Apr;9(2):184–187. doi: 10.1111/j.1445-5994.1979.tb04326.x. [DOI] [PubMed] [Google Scholar]
  239. Wall P. D., Sweet W. H. Temporary abolition of pain in man. Science. 1967 Jan 6;155(3758):108–109. doi: 10.1126/science.155.3758.108. [DOI] [PubMed] [Google Scholar]
  240. Ward J. D., Barnes C. G., Fisher D. J., Jessop J. D., Baker R. W. Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet. 1971 Feb 27;1(7696):428–430. doi: 10.1016/s0140-6736(71)92415-9. [DOI] [PubMed] [Google Scholar]
  241. Ward N. G., Bloom V. L., Friedel R. O. The effectiveness of tricyclic antidepressants in the treatment of coexisting pain and depression. Pain. 1979 Dec;7(3):331–341. doi: 10.1016/0304-3959(79)90089-7. [DOI] [PubMed] [Google Scholar]
  242. Watson C. P., Evans R. J., Reed K., Merskey H., Goldsmith L., Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 1982 Jun;32(6):671–673. doi: 10.1212/wnl.32.6.671. [DOI] [PubMed] [Google Scholar]
  243. Whitley R. J., Ch'ien L. T., Dolin R., Galasso G. J., Alford C. A., Jr Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976 May 27;294(22):1193–1199. doi: 10.1056/NEJM197605272942201. [DOI] [PubMed] [Google Scholar]
  244. Whitley R. J., Soong S. J., Dolin R., Betts R., Linnemann C., Jr, Alford C. A., Jr Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N Engl J Med. 1982 Oct 14;307(16):971–975. doi: 10.1056/NEJM198210143071602. [DOI] [PubMed] [Google Scholar]
  245. Wiegandt H. Structure and specificity of gangliosides. Adv Exp Med Biol. 1976;71(00):3–14. doi: 10.1007/978-1-4614-4614-9_1. [DOI] [PubMed] [Google Scholar]
  246. Wilton T. D. Tegretol in the treatment of diabetic neuropathy. S Afr Med J. 1974 Apr 27;48(20):869–872. [PubMed] [Google Scholar]
  247. Winegrad A. I., Simmons D. A., Martin D. B. Has one diabetic complication been explained? N Engl J Med. 1983 Jan 20;308(3):152–154. doi: 10.1056/NEJM198301203080309. [DOI] [PubMed] [Google Scholar]
  248. Yatzidis H., Koutsicos D., Alaveras A. G., Papastephanidis C., Frangos-Plemenos M. Biotin for neurologic disorders of uremia. N Engl J Med. 1981 Sep 24;305(13):764–764. doi: 10.1056/NEJM198109243051313. [DOI] [PubMed] [Google Scholar]
  249. Yawalkar S. J., McDougall A. C., Languillon J., Ghosh S., Hajra S. K., Opromolla D. V., Tonello C. J. Once-monthly rifampicin plus daily dapsone in initial treatment of lepromatous leprosy. Lancet. 1982 May 29;1(8283):1199–1202. doi: 10.1016/s0140-6736(82)92334-0. [DOI] [PubMed] [Google Scholar]
  250. Young R. J., Ewing D. J., Clarke B. F. A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes. 1983 Oct;32(10):938–942. doi: 10.2337/diab.32.10.938. [DOI] [PubMed] [Google Scholar]
  251. Yuill G. M., Swinburn W. R., Liversedge L. A. Treatment of polyneuropathy with azathioprine. Lancet. 1970 Oct 24;2(7678):854–856. doi: 10.1016/s0140-6736(70)92019-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES